UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review

CNS drugs, 2014-05, Vol.28 (5), p.421-453

2014

Volltextzugriff (PDF)

Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

Acta psychiatrica Scandinavica, 2015-08, Vol.132 (2), p.97-108

2015

Volltextzugriff (PDF)

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

European psychiatry, 2011-04, Vol.26 (3), p.144-158

2011

Volltextzugriff (PDF)

Euthanasia of a person with a psychiatric disorder does not violate the European Convention on Human Rights ( Mortier v. Belgium [no. 78017/17])

European psychiatry, 2022-11, Vol.65 (1), p.e80-e80, Article e80

2022

Volltextzugriff (PDF)

Promotion of cardiorespiratory fitness in schizophrenia: a clinical overview and meta-analysis

Acta psychiatrica Scandinavica, 2015-08, Vol.132 (2), p.131-143

2015

Volltextzugriff (PDF)

Second-generation antipsychotics and constipation: A review of the literature

European psychiatry, 2011-01, Vol.26 (1), p.34-44

2011

Volltextzugriff (PDF)

Sustainability in Dutch and Flemish mental healthcare: A descriptive and comparative study

European psychiatry, 2023-03, Vol.66 (S1), p.S752-S752

2023

Volltextzugriff (PDF)

Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection

BMC psychiatry, 2020-11, Vol.20 (1), p.528-528, Article 528

2020

Volltextzugriff (PDF)

Differential associations of childhood adversity subtypes and psychopathology in men and women

European psychiatry, 2023-03, Vol.66 (S1), p.S80-S81

2023

Volltextzugriff (PDF)

Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time

Human psychopharmacology, 2017-03, Vol.32 (2), p.e2579-n/a

2017

Volltextzugriff (PDF)

The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis

Acta psychiatrica Scandinavica, 2015-08, Vol.132 (2), p.144-157

2015

Volltextzugriff (PDF)

Affective wellbeing moderates the association between polygenic risk score for neuroticism and change in neuroticism

European psychiatry, 2023-03, Vol.66 (S1), p.S175-S175

2023

Volltextzugriff (PDF)

Parsing the components of the psychomotor syndrome in schizophrenia

Acta psychiatrica Scandinavica, 2012-10, Vol.126 (4), p.256-265

2012

Volltextzugriff (PDF)

Abnormal glucose metabolism in patients treated with antipsychotics

Diabetes & metabolism, 2007-06, Vol.33 (3), p.169-175

2007

Volltextzugriff (PDF)

Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients

Schizophrenia bulletin, 2013-03, Vol.39 (2), p.295-305

2013

Volltextzugriff (PDF)

Evaluation of the association between insight and symptoms in a large sample of patients with schizophrenia

European psychiatry, 2009-12, Vol.24 (8), p.507-512

2009

Volltextzugriff (PDF)

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

Clinical practice and epidemiology in mental health, 2006-06, Vol.2 (1), p.14-14

2006

Volltextzugriff (PDF)

Creativity and Psychiatric Illness: The Search for a Missing Link - An Historical Context for Current Research

Psychopathology, 2013-04, Vol.46 (3), p.136-144

2013

Volltextzugriff (PDF)

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

British journal of psychiatry, 2011-08, Vol.199 (2), p.99-105

2011

Volltextzugriff (PDF)

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

Acta psychiatrica Scandinavica, 2016-01, Vol.133 (1), p.5-22

2016

Volltextzugriff (PDF)

A study of the family burden of 150 family members of schizophrenic patients

European psychiatry, 2004-11, Vol.19 (7), p.395-401

2004

Volltextzugriff (PDF)

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

European psychiatry, 2009-09, Vol.24 (6), p.412-424

2009

Volltextzugriff (PDF)

Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis

Acta psychiatrica Scandinavica, 2016-05, Vol.133 (5), p.341-351

2016

Volltextzugriff (PDF)

Promotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin?

Acta psychiatrica Scandinavica, 2015-08, Vol.132 (2), p.83-85

2015

Volltextzugriff (PDF)

The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis

Acta psychiatrica Scandinavica, 2015-02, Vol.131 (2), p.75-88

2015

Volltextzugriff (PDF)

1 – 25 von 516

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(416)
Mit Volltextzugriff
(420)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(197)
Humans
(183)
Psychiatry
(142)
Male
(98)
Female
(92)
Schizophrenia
(87)
Biological And Medical Sciences
(80)
Medical Sciences
(78)
Adult
(72)
Middle Aged
(60)
Psychology. Psychoanalysis. Psychiatry
(51)
Anesthesiology
(50)
Psychopathology. Psychiatry
(49)
Internal Medicine
(47)
Adult And Adolescent Clinical Studies
(38)
Psychoses
(36)
Aged
(32)
Risk Factors
(32)
Antipsychotic Agents - Adverse Effects
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review

Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

Euthanasia of a person with a psychiatric disorder does not violate the European Convention on Human Rights ( Mortier v. Belgium [no. 78017/17])

Promotion of cardiorespiratory fitness in schizophrenia: a clinical overview and meta-analysis

Second-generation antipsychotics and constipation: A review of the literature

Sustainability in Dutch and Flemish mental healthcare: A descriptive and comparative study

Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selection

Differential associations of childhood adversity subtypes and psychopathology in men and women

Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time

The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis

Affective wellbeing moderates the association between polygenic risk score for neuroticism and change in neuroticism

Parsing the components of the psychomotor syndrome in schizophrenia

Abnormal glucose metabolism in patients treated with antipsychotics

Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients

Evaluation of the association between insight and symptoms in a large sample of patients with schizophrenia

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

Creativity and Psychiatric Illness: The Search for a Missing Link - An Historical Context for Current Research

Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation

Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review

A study of the family burden of 150 family members of schizophrenic patients

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis

Promotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin?

The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis

Suchergebnisse filtern